Pectolvan C manufactured by Farmak JSC is a medicinal product registered in accordance with the current Register of Medicinal Products and is authorized for medical use in Ukraine.
However, in December 2017, Farmak JSC recalled six batches of Pectolvan C from the market due to minor deviations in the ‘Description’ parameter. Farmak JSC has uncompromising attitude towards quality, so the company has notified the State Service of Ukraine for Medicines and all distributors in due time, in accordance with the GMP requirements.
Today, Pectolvan C, just like all other Farmak products available on the market, in pharmacies and from distributors, complies with the quality standards and is authorized for medical use in Ukraine.
USD 500,000 to be provided by the Company will be used for the development of KSE (Kyiv School of Economics) to improve education in Ukraine. The pharmaceutical company Farmak will provide KSE with monetary funds to equip the training rooms and areas of the new campus, as well as to develop existing and launch new majors, […]
The Shostka Children’s Hospital that has made available inpatient treatment of children diagnosed with COVID-19 since April 2021 has been provided with medical and diagnostic equipment purchased by the Zhebrivski Family Charitable Foundation. The operating COVID-19 treatment unit at the Shostka Hospital will make it possible to provide the qualitative ...
Farmak as a leader of the Ukrainian pharmaceutical market* has been included in the rating of TOP 200 largest Ukrainian companies in terms of tax payments for 2020 and has become the only representative of the pharmaceutical industry in this rating. At year-end 2020, the Company transferred UAH 712.1 million of taxes and fees to […]